nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP2C9—brain cancer	0.462	1	CbGaD
Mirtazapine—CYP2D6—Lomustine—brain cancer	0.0432	0.202	CbGbCtD
Mirtazapine—CYP1A2—Carmustine—brain cancer	0.0428	0.2	CbGbCtD
Mirtazapine—CYP2D6—Hydroxyurea—brain cancer	0.0327	0.153	CbGbCtD
Mirtazapine—CYP3A4—Temozolomide—brain cancer	0.0323	0.151	CbGbCtD
Mirtazapine—CYP3A4—Lomustine—brain cancer	0.0275	0.128	CbGbCtD
Mirtazapine—CYP2C8—Etoposide—brain cancer	0.0164	0.0764	CbGbCtD
Mirtazapine—CYP1A2—Etoposide—brain cancer	0.0127	0.0592	CbGbCtD
Mirtazapine—HTR3A—fourth ventricle—brain cancer	0.00852	0.0726	CbGeAlD
Mirtazapine—HTR2C—choroid plexus—brain cancer	0.00677	0.0578	CbGeAlD
Mirtazapine—CYP3A4—Etoposide—brain cancer	0.00664	0.031	CbGbCtD
Mirtazapine—DRD3—telencephalic ventricle—brain cancer	0.00357	0.0304	CbGeAlD
Mirtazapine—HTR2A—choroid plexus—brain cancer	0.0034	0.029	CbGeAlD
Mirtazapine—HTR3A—cranial nerve—brain cancer	0.00303	0.0259	CbGeAlD
Mirtazapine—HRH1—nose—brain cancer	0.00262	0.0224	CbGeAlD
Mirtazapine—HTR7—vein—brain cancer	0.00249	0.0212	CbGeAlD
Mirtazapine—HRH3—hindbrain—brain cancer	0.00243	0.0207	CbGeAlD
Mirtazapine—SLC6A3—telencephalic ventricle—brain cancer	0.00205	0.0175	CbGeAlD
Mirtazapine—HTR2C—telencephalic ventricle—brain cancer	0.00198	0.0169	CbGeAlD
Mirtazapine—HTR7—cranial nerve—brain cancer	0.00196	0.0167	CbGeAlD
Mirtazapine—HTR7—pons—brain cancer	0.00194	0.0165	CbGeAlD
Mirtazapine—HTR2A—trigeminal nerve—brain cancer	0.00172	0.0146	CbGeAlD
Mirtazapine—HTR2A—cerebellar cortex—brain cancer	0.00171	0.0146	CbGeAlD
Mirtazapine—HTR1A—telencephalic ventricle—brain cancer	0.00167	0.0142	CbGeAlD
Mirtazapine—HTR7—telencephalic ventricle—brain cancer	0.0016	0.0136	CbGeAlD
Mirtazapine—HTR2A—vein—brain cancer	0.00155	0.0132	CbGeAlD
Mirtazapine—HTR3A—ganglion—brain cancer	0.00154	0.0131	CbGeAlD
Mirtazapine—DRD2—telencephalic ventricle—brain cancer	0.00151	0.0129	CbGeAlD
Mirtazapine—HRH3—brainstem—brain cancer	0.00139	0.0119	CbGeAlD
Mirtazapine—SLC6A3—ganglion—brain cancer	0.00128	0.0109	CbGeAlD
Mirtazapine—HRH3—telencephalon—brain cancer	0.00124	0.0105	CbGeAlD
Mirtazapine—HTR2C—ganglion—brain cancer	0.00124	0.0105	CbGeAlD
Mirtazapine—HTR2A—cranial nerve—brain cancer	0.00122	0.0104	CbGeAlD
Mirtazapine—HTR2A—pons—brain cancer	0.00121	0.0103	CbGeAlD
Mirtazapine—SLC6A4—ganglion—brain cancer	0.00117	0.00998	CbGeAlD
Mirtazapine—HTR1A—ganglion—brain cancer	0.00104	0.00886	CbGeAlD
Mirtazapine—SLC6A2—ganglion—brain cancer	0.00103	0.00879	CbGeAlD
Mirtazapine—HTR2A—telencephalic ventricle—brain cancer	0.000996	0.00849	CbGeAlD
Mirtazapine—HTR7—ganglion—brain cancer	0.000994	0.00847	CbGeAlD
Mirtazapine—SLC6A3—hindbrain—brain cancer	0.000969	0.00826	CbGeAlD
Mirtazapine—DRD2—ganglion—brain cancer	0.00094	0.00801	CbGeAlD
Mirtazapine—SLC6A4—hindbrain—brain cancer	0.000888	0.00757	CbGeAlD
Mirtazapine—HTR2A—pineal body—brain cancer	0.000864	0.00736	CbGeAlD
Mirtazapine—HTR7—endothelium—brain cancer	0.000857	0.0073	CbGeAlD
Mirtazapine—HTR7—blood vessel—brain cancer	0.00079	0.00674	CbGeAlD
Mirtazapine—HTR1A—hindbrain—brain cancer	0.000789	0.00672	CbGeAlD
Mirtazapine—HRH3—head—brain cancer	0.00077	0.00656	CbGeAlD
Mirtazapine—HTR7—hindbrain—brain cancer	0.000754	0.00642	CbGeAlD
Mirtazapine—ADRA1A—hindbrain—brain cancer	0.000727	0.0062	CbGeAlD
Mirtazapine—DRD2—hindbrain—brain cancer	0.000713	0.00607	CbGeAlD
Mirtazapine—HRH3—central nervous system—brain cancer	0.000703	0.00599	CbGeAlD
Mirtazapine—HRH3—cerebellum—brain cancer	0.000687	0.00585	CbGeAlD
Mirtazapine—HTR3A—brainstem—brain cancer	0.000668	0.00569	CbGeAlD
Mirtazapine—HTR2A—ganglion—brain cancer	0.00062	0.00528	CbGeAlD
Mirtazapine—HTR3A—telencephalon—brain cancer	0.000593	0.00505	CbGeAlD
Mirtazapine—HRH3—brain—brain cancer	0.000558	0.00475	CbGeAlD
Mirtazapine—SLC6A3—brainstem—brain cancer	0.000556	0.00474	CbGeAlD
Mirtazapine—DRD4—brain—brain cancer	0.00055	0.00469	CbGeAlD
Mirtazapine—HTR2C—brainstem—brain cancer	0.000537	0.00458	CbGeAlD
Mirtazapine—HTR2A—endothelium—brain cancer	0.000534	0.00456	CbGeAlD
Mirtazapine—DRD3—head—brain cancer	0.000534	0.00455	CbGeAlD
Mirtazapine—SLC6A4—brainstem—brain cancer	0.000509	0.00434	CbGeAlD
Mirtazapine—SLC6A3—telencephalon—brain cancer	0.000493	0.0042	CbGeAlD
Mirtazapine—HTR2A—blood vessel—brain cancer	0.000493	0.0042	CbGeAlD
Mirtazapine—DRD3—central nervous system—brain cancer	0.000487	0.00415	CbGeAlD
Mirtazapine—HTR2C—telencephalon—brain cancer	0.000477	0.00406	CbGeAlD
Mirtazapine—OPRK1—head—brain cancer	0.000476	0.00405	CbGeAlD
Mirtazapine—HTR2A—hindbrain—brain cancer	0.00047	0.00401	CbGeAlD
Mirtazapine—ADRB1—telencephalon—brain cancer	0.000468	0.00399	CbGeAlD
Mirtazapine—HTR1A—brainstem—brain cancer	0.000452	0.00385	CbGeAlD
Mirtazapine—SLC6A4—telencephalon—brain cancer	0.000452	0.00385	CbGeAlD
Mirtazapine—SLC6A2—brainstem—brain cancer	0.000448	0.00382	CbGeAlD
Mirtazapine—HTR2B—telencephalon—brain cancer	0.000448	0.00382	CbGeAlD
Mirtazapine—OPRK1—central nervous system—brain cancer	0.000434	0.0037	CbGeAlD
Mirtazapine—HTR7—brainstem—brain cancer	0.000432	0.00368	CbGeAlD
Mirtazapine—CYP2D6—hindbrain—brain cancer	0.000428	0.00365	CbGeAlD
Mirtazapine—OPRK1—cerebellum—brain cancer	0.000424	0.00362	CbGeAlD
Mirtazapine—ADRA1A—brainstem—brain cancer	0.000417	0.00355	CbGeAlD
Mirtazapine—DRD2—brainstem—brain cancer	0.000408	0.00348	CbGeAlD
Mirtazapine—HTR1A—telencephalon—brain cancer	0.000401	0.00342	CbGeAlD
Mirtazapine—SLC6A2—telencephalon—brain cancer	0.000398	0.00339	CbGeAlD
Mirtazapine—DRD3—brain—brain cancer	0.000387	0.0033	CbGeAlD
Mirtazapine—HTR7—telencephalon—brain cancer	0.000383	0.00327	CbGeAlD
Mirtazapine—HTR2C—medulla oblongata—brain cancer	0.000374	0.00319	CbGeAlD
Mirtazapine—ADRA1A—telencephalon—brain cancer	0.00037	0.00315	CbGeAlD
Mirtazapine—HTR3A—head—brain cancer	0.000369	0.00315	CbGeAlD
Mirtazapine—DRD2—telencephalon—brain cancer	0.000362	0.00309	CbGeAlD
Mirtazapine—SLC6A3—midbrain—brain cancer	0.000354	0.00302	CbGeAlD
Mirtazapine—ADRA2C—telencephalon—brain cancer	0.000352	0.003	CbGeAlD
Mirtazapine—SLC6A3—spinal cord—brain cancer	0.000345	0.00294	CbGeAlD
Mirtazapine—OPRK1—brain—brain cancer	0.000345	0.00294	CbGeAlD
Mirtazapine—HTR2C—midbrain—brain cancer	0.000342	0.00292	CbGeAlD
Mirtazapine—HTR3A—central nervous system—brain cancer	0.000337	0.00287	CbGeAlD
Mirtazapine—HTR2C—spinal cord—brain cancer	0.000334	0.00285	CbGeAlD
Mirtazapine—SLC6A2—gonad—brain cancer	0.000332	0.00283	CbGeAlD
Mirtazapine—SLC6A4—midbrain—brain cancer	0.000324	0.00277	CbGeAlD
Mirtazapine—HTR7—gonad—brain cancer	0.00032	0.00273	CbGeAlD
Mirtazapine—SLC6A4—spinal cord—brain cancer	0.000317	0.0027	CbGeAlD
Mirtazapine—SLC6A2—medulla oblongata—brain cancer	0.000313	0.00266	CbGeAlD
Mirtazapine—SLC6A3—head—brain cancer	0.000307	0.00262	CbGeAlD
Mirtazapine—HTR7—medulla oblongata—brain cancer	0.000301	0.00257	CbGeAlD
Mirtazapine—HTR2C—head—brain cancer	0.000297	0.00253	CbGeAlD
Mirtazapine—DRD2—pituitary gland—brain cancer	0.000295	0.00252	CbGeAlD
Mirtazapine—ADRB1—endocrine gland—brain cancer	0.000295	0.00251	CbGeAlD
Mirtazapine—ADRB1—head—brain cancer	0.000291	0.00248	CbGeAlD
Mirtazapine—HTR1A—midbrain—brain cancer	0.000288	0.00246	CbGeAlD
Mirtazapine—ADRA2C—pituitary gland—brain cancer	0.000287	0.00245	CbGeAlD
Mirtazapine—HRH1—telencephalon—brain cancer	0.000286	0.00244	CbGeAlD
Mirtazapine—SLC6A4—endocrine gland—brain cancer	0.000285	0.00243	CbGeAlD
Mirtazapine—Weight decreased—Temozolomide—brain cancer	0.000284	0.00187	CcSEcCtD
Mirtazapine—Stomatitis—Carmustine—brain cancer	0.000282	0.00186	CcSEcCtD
Mirtazapine—SLC6A4—head—brain cancer	0.000281	0.0024	CbGeAlD
Mirtazapine—ADRA2A—telencephalon—brain cancer	0.000281	0.0024	CbGeAlD
Mirtazapine—HTR1A—spinal cord—brain cancer	0.000281	0.0024	CbGeAlD
Mirtazapine—Urinary tract infection—Carmustine—brain cancer	0.000281	0.00186	CcSEcCtD
Mirtazapine—Pneumonia—Temozolomide—brain cancer	0.000281	0.00186	CcSEcCtD
Mirtazapine—Anorexia—Procarbazine—brain cancer	0.000281	0.00186	CcSEcCtD
Mirtazapine—SLC6A3—central nervous system—brain cancer	0.00028	0.00239	CbGeAlD
Mirtazapine—HTR2B—head—brain cancer	0.000279	0.00238	CbGeAlD
Mirtazapine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000277	0.00183	CcSEcCtD
Mirtazapine—ADRA2C—medulla oblongata—brain cancer	0.000277	0.00236	CbGeAlD
Mirtazapine—Nausea—Lomustine—brain cancer	0.000276	0.00182	CcSEcCtD
Mirtazapine—Hypotension—Procarbazine—brain cancer	0.000275	0.00182	CcSEcCtD
Mirtazapine—HTR7—midbrain—brain cancer	0.000275	0.00235	CbGeAlD
Mirtazapine—SLC6A3—cerebellum—brain cancer	0.000274	0.00233	CbGeAlD
Mirtazapine—Stomatitis—Temozolomide—brain cancer	0.000272	0.0018	CcSEcCtD
Mirtazapine—Urinary tract infection—Temozolomide—brain cancer	0.000272	0.00179	CcSEcCtD
Mirtazapine—HTR2C—central nervous system—brain cancer	0.000271	0.00231	CbGeAlD
Mirtazapine—HTR2A—brainstem—brain cancer	0.000269	0.0023	CbGeAlD
Mirtazapine—HTR7—spinal cord—brain cancer	0.000269	0.00229	CbGeAlD
Mirtazapine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000269	0.00177	CcSEcCtD
Mirtazapine—HTR3A—brain—brain cancer	0.000267	0.00228	CbGeAlD
Mirtazapine—Insomnia—Procarbazine—brain cancer	0.000267	0.00176	CcSEcCtD
Mirtazapine—CYP2C8—pituitary gland—brain cancer	0.000266	0.00227	CbGeAlD
Mirtazapine—ADRB1—central nervous system—brain cancer	0.000266	0.00227	CbGeAlD
Mirtazapine—Paraesthesia—Procarbazine—brain cancer	0.000265	0.00175	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Temozolomide—brain cancer	0.000264	0.00175	CcSEcCtD
Mirtazapine—Sinusitis—Temozolomide—brain cancer	0.000262	0.00173	CcSEcCtD
Mirtazapine—Somnolence—Procarbazine—brain cancer	0.000262	0.00173	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000261	0.00173	CcSEcCtD
Mirtazapine—DRD2—midbrain—brain cancer	0.00026	0.00222	CbGeAlD
Mirtazapine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000259	0.00171	CcSEcCtD
Mirtazapine—Anaemia—Hydroxyurea—brain cancer	0.000258	0.00171	CcSEcCtD
Mirtazapine—Hallucination—Carmustine—brain cancer	0.000258	0.00171	CcSEcCtD
Mirtazapine—Hypoaesthesia—Carmustine—brain cancer	0.000258	0.00171	CcSEcCtD
Mirtazapine—SLC6A4—central nervous system—brain cancer	0.000257	0.00219	CbGeAlD
Mirtazapine—Decreased appetite—Procarbazine—brain cancer	0.000256	0.00169	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000256	0.00169	CcSEcCtD
Mirtazapine—Oedema peripheral—Carmustine—brain cancer	0.000256	0.00169	CcSEcCtD
Mirtazapine—HTR2B—central nervous system—brain cancer	0.000254	0.00217	CbGeAlD
Mirtazapine—Fatigue—Procarbazine—brain cancer	0.000254	0.00168	CcSEcCtD
Mirtazapine—ADRA2C—midbrain—brain cancer	0.000253	0.00216	CbGeAlD
Mirtazapine—HTR1A—endocrine gland—brain cancer	0.000253	0.00216	CbGeAlD
Mirtazapine—Malaise—Hydroxyurea—brain cancer	0.000252	0.00167	CcSEcCtD
Mirtazapine—Pain—Procarbazine—brain cancer	0.000252	0.00167	CcSEcCtD
Mirtazapine—Constipation—Procarbazine—brain cancer	0.000252	0.00167	CcSEcCtD
Mirtazapine—SLC6A2—endocrine gland—brain cancer	0.000251	0.00214	CbGeAlD
Mirtazapine—Hepatitis—Temozolomide—brain cancer	0.000251	0.00166	CcSEcCtD
Mirtazapine—Leukopenia—Hydroxyurea—brain cancer	0.00025	0.00165	CcSEcCtD
Mirtazapine—HTR1A—head—brain cancer	0.00025	0.00213	CbGeAlD
Mirtazapine—Hypoaesthesia—Temozolomide—brain cancer	0.00025	0.00165	CcSEcCtD
Mirtazapine—Hallucination—Temozolomide—brain cancer	0.00025	0.00165	CcSEcCtD
Mirtazapine—Pharyngitis—Temozolomide—brain cancer	0.000249	0.00165	CcSEcCtD
Mirtazapine—Urinary tract disorder—Temozolomide—brain cancer	0.000248	0.00164	CcSEcCtD
Mirtazapine—SLC6A2—head—brain cancer	0.000248	0.00211	CbGeAlD
Mirtazapine—Oedema peripheral—Temozolomide—brain cancer	0.000247	0.00163	CcSEcCtD
Mirtazapine—ADRA2C—spinal cord—brain cancer	0.000247	0.0021	CbGeAlD
Mirtazapine—Urethral disorder—Temozolomide—brain cancer	0.000246	0.00162	CcSEcCtD
Mirtazapine—CYP2D6—brainstem—brain cancer	0.000245	0.00209	CbGeAlD
Mirtazapine—Sweating increased—Etoposide—brain cancer	0.000244	0.00161	CcSEcCtD
Mirtazapine—Feeling abnormal—Procarbazine—brain cancer	0.000243	0.0016	CcSEcCtD
Mirtazapine—Eye disorder—Carmustine—brain cancer	0.000243	0.0016	CcSEcCtD
Mirtazapine—Convulsion—Hydroxyurea—brain cancer	0.000242	0.0016	CcSEcCtD
Mirtazapine—HTR7—endocrine gland—brain cancer	0.000242	0.00206	CbGeAlD
Mirtazapine—Gastrointestinal pain—Procarbazine—brain cancer	0.000241	0.00159	CcSEcCtD
Mirtazapine—HTR2A—telencephalon—brain cancer	0.000239	0.00204	CbGeAlD
Mirtazapine—HTR7—head—brain cancer	0.000239	0.00203	CbGeAlD
Mirtazapine—Pancytopenia—Etoposide—brain cancer	0.000238	0.00157	CcSEcCtD
Mirtazapine—Erythema multiforme—Temozolomide—brain cancer	0.000237	0.00157	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000236	0.00156	CcSEcCtD
Mirtazapine—Discomfort—Hydroxyurea—brain cancer	0.000235	0.00155	CcSEcCtD
Mirtazapine—ADRA2A—gonad—brain cancer	0.000235	0.002	CbGeAlD
Mirtazapine—Neutropenia—Etoposide—brain cancer	0.000234	0.00155	CcSEcCtD
Mirtazapine—Eye disorder—Temozolomide—brain cancer	0.000234	0.00155	CcSEcCtD
Mirtazapine—Urticaria—Procarbazine—brain cancer	0.000234	0.00155	CcSEcCtD
Mirtazapine—Tinnitus—Temozolomide—brain cancer	0.000234	0.00155	CcSEcCtD
Mirtazapine—ADRA1A—endocrine gland—brain cancer	0.000233	0.00199	CbGeAlD
Mirtazapine—Abdominal pain—Procarbazine—brain cancer	0.000233	0.00154	CcSEcCtD
Mirtazapine—Body temperature increased—Procarbazine—brain cancer	0.000233	0.00154	CcSEcCtD
Mirtazapine—Cardiac disorder—Temozolomide—brain cancer	0.000233	0.00154	CcSEcCtD
Mirtazapine—Arrhythmia—Carmustine—brain cancer	0.000232	0.00153	CcSEcCtD
Mirtazapine—ADRA1A—head—brain cancer	0.00023	0.00196	CbGeAlD
Mirtazapine—Alopecia—Carmustine—brain cancer	0.000229	0.00152	CcSEcCtD
Mirtazapine—ADRA2A—pituitary gland—brain cancer	0.000229	0.00195	CbGeAlD
Mirtazapine—DRD2—endocrine gland—brain cancer	0.000229	0.00195	CbGeAlD
Mirtazapine—Oedema—Hydroxyurea—brain cancer	0.000228	0.00151	CcSEcCtD
Mirtazapine—HTR1A—central nervous system—brain cancer	0.000228	0.00194	CbGeAlD
Mirtazapine—Angiopathy—Temozolomide—brain cancer	0.000228	0.0015	CcSEcCtD
Mirtazapine—Mental disorder—Carmustine—brain cancer	0.000227	0.0015	CcSEcCtD
Mirtazapine—Infection—Hydroxyurea—brain cancer	0.000227	0.0015	CcSEcCtD
Mirtazapine—SLC6A2—central nervous system—brain cancer	0.000226	0.00193	CbGeAlD
Mirtazapine—Malnutrition—Carmustine—brain cancer	0.000226	0.00149	CcSEcCtD
Mirtazapine—DRD2—head—brain cancer	0.000226	0.00192	CbGeAlD
Mirtazapine—Chills—Temozolomide—brain cancer	0.000225	0.00149	CcSEcCtD
Mirtazapine—Pneumonia—Etoposide—brain cancer	0.000225	0.00149	CcSEcCtD
Mirtazapine—Nervous system disorder—Hydroxyurea—brain cancer	0.000224	0.00148	CcSEcCtD
Mirtazapine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000223	0.00148	CcSEcCtD
Mirtazapine—HTR1A—cerebellum—brain cancer	0.000223	0.0019	CbGeAlD
Mirtazapine—SLC6A3—brain—brain cancer	0.000222	0.0019	CbGeAlD
Mirtazapine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000222	0.00146	CcSEcCtD
Mirtazapine—Alopecia—Temozolomide—brain cancer	0.000222	0.00146	CcSEcCtD
Mirtazapine—Skin disorder—Hydroxyurea—brain cancer	0.000222	0.00146	CcSEcCtD
Mirtazapine—ADRA2A—medulla oblongata—brain cancer	0.000221	0.00188	CbGeAlD
Mirtazapine—Acute coronary syndrome—Etoposide—brain cancer	0.00022	0.00146	CcSEcCtD
Mirtazapine—Mental disorder—Temozolomide—brain cancer	0.00022	0.00145	CcSEcCtD
Mirtazapine—ADRA2C—head—brain cancer	0.000219	0.00187	CbGeAlD
Mirtazapine—Myocardial infarction—Etoposide—brain cancer	0.000219	0.00145	CcSEcCtD
Mirtazapine—Back pain—Carmustine—brain cancer	0.000219	0.00144	CcSEcCtD
Mirtazapine—Malnutrition—Temozolomide—brain cancer	0.000218	0.00144	CcSEcCtD
Mirtazapine—Stomatitis—Etoposide—brain cancer	0.000218	0.00144	CcSEcCtD
Mirtazapine—Jaundice—Etoposide—brain cancer	0.000218	0.00144	CcSEcCtD
Mirtazapine—HTR7—central nervous system—brain cancer	0.000218	0.00186	CbGeAlD
Mirtazapine—CYP2D6—telencephalon—brain cancer	0.000218	0.00186	CbGeAlD
Mirtazapine—Anorexia—Hydroxyurea—brain cancer	0.000217	0.00144	CcSEcCtD
Mirtazapine—Hypersensitivity—Procarbazine—brain cancer	0.000217	0.00143	CcSEcCtD
Mirtazapine—HTR2C—brain—brain cancer	0.000215	0.00183	CbGeAlD
Mirtazapine—Dysgeusia—Temozolomide—brain cancer	0.000214	0.00141	CcSEcCtD
Mirtazapine—HTR7—cerebellum—brain cancer	0.000213	0.00182	CbGeAlD
Mirtazapine—Tremor—Carmustine—brain cancer	0.000212	0.0014	CcSEcCtD
Mirtazapine—Asthenia—Procarbazine—brain cancer	0.000211	0.0014	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Etoposide—brain cancer	0.000211	0.0014	CcSEcCtD
Mirtazapine—Back pain—Temozolomide—brain cancer	0.000211	0.0014	CcSEcCtD
Mirtazapine—ADRB1—brain—brain cancer	0.000211	0.0018	CbGeAlD
Mirtazapine—ADRA1A—central nervous system—brain cancer	0.00021	0.00179	CbGeAlD
Mirtazapine—Anaemia—Carmustine—brain cancer	0.000209	0.00138	CcSEcCtD
Mirtazapine—Agranulocytosis—Etoposide—brain cancer	0.000209	0.00138	CcSEcCtD
Mirtazapine—Pruritus—Procarbazine—brain cancer	0.000209	0.00138	CcSEcCtD
Mirtazapine—Agitation—Carmustine—brain cancer	0.000208	0.00137	CcSEcCtD
Mirtazapine—CYP2C8—endocrine gland—brain cancer	0.000206	0.00176	CbGeAlD
Mirtazapine—DRD2—central nervous system—brain cancer	0.000206	0.00176	CbGeAlD
Mirtazapine—ADRA1A—cerebellum—brain cancer	0.000205	0.00175	CbGeAlD
Mirtazapine—Tremor—Temozolomide—brain cancer	0.000205	0.00135	CcSEcCtD
Mirtazapine—SLC6A4—brain—brain cancer	0.000204	0.00174	CbGeAlD
Mirtazapine—Dyspnoea—Hydroxyurea—brain cancer	0.000203	0.00134	CcSEcCtD
Mirtazapine—Somnolence—Hydroxyurea—brain cancer	0.000203	0.00134	CcSEcCtD
Mirtazapine—Ill-defined disorder—Temozolomide—brain cancer	0.000203	0.00134	CcSEcCtD
Mirtazapine—Leukopenia—Carmustine—brain cancer	0.000202	0.00134	CcSEcCtD
Mirtazapine—HTR2B—brain—brain cancer	0.000202	0.00172	CbGeAlD
Mirtazapine—ADRA2A—midbrain—brain cancer	0.000202	0.00172	CbGeAlD
Mirtazapine—Anaemia—Temozolomide—brain cancer	0.000202	0.00133	CcSEcCtD
Mirtazapine—Diarrhoea—Procarbazine—brain cancer	0.000202	0.00133	CcSEcCtD
Mirtazapine—DRD2—cerebellum—brain cancer	0.000201	0.00172	CbGeAlD
Mirtazapine—Dyspepsia—Hydroxyurea—brain cancer	0.000201	0.00133	CcSEcCtD
Mirtazapine—Agitation—Temozolomide—brain cancer	0.000201	0.00133	CcSEcCtD
Mirtazapine—ADRA2C—central nervous system—brain cancer	0.0002	0.00171	CbGeAlD
Mirtazapine—Hypoaesthesia—Etoposide—brain cancer	0.0002	0.00132	CcSEcCtD
Mirtazapine—HTR2A—gonad—brain cancer	0.0002	0.0017	CbGeAlD
Mirtazapine—Decreased appetite—Hydroxyurea—brain cancer	0.000198	0.00131	CcSEcCtD
Mirtazapine—Urinary tract disorder—Etoposide—brain cancer	0.000198	0.00131	CcSEcCtD
Mirtazapine—ADRA2A—spinal cord—brain cancer	0.000197	0.00168	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000197	0.0013	CcSEcCtD
Mirtazapine—Malaise—Temozolomide—brain cancer	0.000197	0.0013	CcSEcCtD
Mirtazapine—Urethral disorder—Etoposide—brain cancer	0.000197	0.0013	CcSEcCtD
Mirtazapine—Fatigue—Hydroxyurea—brain cancer	0.000197	0.0013	CcSEcCtD
Mirtazapine—Vertigo—Temozolomide—brain cancer	0.000196	0.0013	CcSEcCtD
Mirtazapine—Convulsion—Carmustine—brain cancer	0.000196	0.00129	CcSEcCtD
Mirtazapine—ADRA2C—cerebellum—brain cancer	0.000196	0.00167	CbGeAlD
Mirtazapine—Leukopenia—Temozolomide—brain cancer	0.000195	0.00129	CcSEcCtD
Mirtazapine—Hypertension—Carmustine—brain cancer	0.000195	0.00129	CcSEcCtD
Mirtazapine—Pain—Hydroxyurea—brain cancer	0.000195	0.00129	CcSEcCtD
Mirtazapine—Constipation—Hydroxyurea—brain cancer	0.000195	0.00129	CcSEcCtD
Mirtazapine—Dizziness—Procarbazine—brain cancer	0.000195	0.00129	CcSEcCtD
Mirtazapine—HTR2A—pituitary gland—brain cancer	0.000195	0.00166	CbGeAlD
Mirtazapine—Palpitations—Temozolomide—brain cancer	0.000193	0.00128	CcSEcCtD
Mirtazapine—CYP1A2—endocrine gland—brain cancer	0.000193	0.00164	CbGeAlD
Mirtazapine—Myalgia—Carmustine—brain cancer	0.000192	0.00127	CcSEcCtD
Mirtazapine—Chest pain—Carmustine—brain cancer	0.000192	0.00127	CcSEcCtD
Mirtazapine—Anxiety—Carmustine—brain cancer	0.000192	0.00127	CcSEcCtD
Mirtazapine—Cough—Temozolomide—brain cancer	0.000191	0.00126	CcSEcCtD
Mirtazapine—Erythema multiforme—Etoposide—brain cancer	0.00019	0.00125	CcSEcCtD
Mirtazapine—Convulsion—Temozolomide—brain cancer	0.000189	0.00125	CcSEcCtD
Mirtazapine—Hypertension—Temozolomide—brain cancer	0.000189	0.00125	CcSEcCtD
Mirtazapine—Feeling abnormal—Hydroxyurea—brain cancer	0.000188	0.00124	CcSEcCtD
Mirtazapine—HTR2A—medulla oblongata—brain cancer	0.000188	0.0016	CbGeAlD
Mirtazapine—Eye disorder—Etoposide—brain cancer	0.000188	0.00124	CcSEcCtD
Mirtazapine—Vomiting—Procarbazine—brain cancer	0.000187	0.00124	CcSEcCtD
Mirtazapine—Cardiac disorder—Etoposide—brain cancer	0.000186	0.00123	CcSEcCtD
Mirtazapine—Confusional state—Carmustine—brain cancer	0.000186	0.00123	CcSEcCtD
Mirtazapine—Arthralgia—Temozolomide—brain cancer	0.000186	0.00123	CcSEcCtD
Mirtazapine—Myalgia—Temozolomide—brain cancer	0.000186	0.00123	CcSEcCtD
Mirtazapine—Rash—Procarbazine—brain cancer	0.000186	0.00123	CcSEcCtD
Mirtazapine—Dermatitis—Procarbazine—brain cancer	0.000186	0.00123	CcSEcCtD
Mirtazapine—Anxiety—Temozolomide—brain cancer	0.000185	0.00122	CcSEcCtD
Mirtazapine—Headache—Procarbazine—brain cancer	0.000185	0.00122	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000185	0.00122	CcSEcCtD
Mirtazapine—Oedema—Carmustine—brain cancer	0.000184	0.00122	CcSEcCtD
Mirtazapine—Discomfort—Temozolomide—brain cancer	0.000184	0.00121	CcSEcCtD
Mirtazapine—Infection—Carmustine—brain cancer	0.000183	0.00121	CcSEcCtD
Mirtazapine—CYP2C9—endocrine gland—brain cancer	0.000183	0.00156	CbGeAlD
Mirtazapine—Angiopathy—Etoposide—brain cancer	0.000182	0.0012	CcSEcCtD
Mirtazapine—Dry mouth—Temozolomide—brain cancer	0.000182	0.0012	CcSEcCtD
Mirtazapine—HTR1A—brain—brain cancer	0.000181	0.00154	CbGeAlD
Mirtazapine—Thrombocytopenia—Carmustine—brain cancer	0.000181	0.00119	CcSEcCtD
Mirtazapine—HRH1—endocrine gland—brain cancer	0.000181	0.00154	CbGeAlD
Mirtazapine—Body temperature increased—Hydroxyurea—brain cancer	0.00018	0.00119	CcSEcCtD
Mirtazapine—Chills—Etoposide—brain cancer	0.00018	0.00119	CcSEcCtD
Mirtazapine—Tachycardia—Carmustine—brain cancer	0.00018	0.00119	CcSEcCtD
Mirtazapine—Confusional state—Temozolomide—brain cancer	0.00018	0.00119	CcSEcCtD
Mirtazapine—SLC6A2—brain—brain cancer	0.000179	0.00153	CbGeAlD
Mirtazapine—HRH1—head—brain cancer	0.000178	0.00152	CbGeAlD
Mirtazapine—Oedema—Temozolomide—brain cancer	0.000178	0.00118	CcSEcCtD
Mirtazapine—Alopecia—Etoposide—brain cancer	0.000177	0.00117	CcSEcCtD
Mirtazapine—ADRA2A—endocrine gland—brain cancer	0.000177	0.00151	CbGeAlD
Mirtazapine—Infection—Temozolomide—brain cancer	0.000177	0.00117	CcSEcCtD
Mirtazapine—Anorexia—Carmustine—brain cancer	0.000176	0.00116	CcSEcCtD
Mirtazapine—ADRA2A—head—brain cancer	0.000175	0.00149	CbGeAlD
Mirtazapine—Nausea—Procarbazine—brain cancer	0.000175	0.00116	CcSEcCtD
Mirtazapine—Nervous system disorder—Temozolomide—brain cancer	0.000175	0.00115	CcSEcCtD
Mirtazapine—Thrombocytopenia—Temozolomide—brain cancer	0.000174	0.00115	CcSEcCtD
Mirtazapine—Skin disorder—Temozolomide—brain cancer	0.000173	0.00114	CcSEcCtD
Mirtazapine—HTR7—brain—brain cancer	0.000173	0.00147	CbGeAlD
Mirtazapine—Hypotension—Carmustine—brain cancer	0.000172	0.00114	CcSEcCtD
Mirtazapine—Hyperhidrosis—Temozolomide—brain cancer	0.000172	0.00114	CcSEcCtD
Mirtazapine—HTR2A—midbrain—brain cancer	0.000172	0.00146	CbGeAlD
Mirtazapine—Dysgeusia—Etoposide—brain cancer	0.000171	0.00113	CcSEcCtD
Mirtazapine—Anorexia—Temozolomide—brain cancer	0.00017	0.00112	CcSEcCtD
Mirtazapine—Back pain—Etoposide—brain cancer	0.000169	0.00112	CcSEcCtD
Mirtazapine—Hypersensitivity—Hydroxyurea—brain cancer	0.000168	0.00111	CcSEcCtD
Mirtazapine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000168	0.00111	CcSEcCtD
Mirtazapine—HTR2A—spinal cord—brain cancer	0.000168	0.00143	CbGeAlD
Mirtazapine—ADRA1A—brain—brain cancer	0.000167	0.00142	CbGeAlD
Mirtazapine—Insomnia—Carmustine—brain cancer	0.000167	0.0011	CcSEcCtD
Mirtazapine—Paraesthesia—Carmustine—brain cancer	0.000166	0.00109	CcSEcCtD
Mirtazapine—Dyspnoea—Carmustine—brain cancer	0.000164	0.00109	CcSEcCtD
Mirtazapine—Somnolence—Carmustine—brain cancer	0.000164	0.00108	CcSEcCtD
Mirtazapine—Asthenia—Hydroxyurea—brain cancer	0.000164	0.00108	CcSEcCtD
Mirtazapine—DRD2—brain—brain cancer	0.000164	0.00139	CbGeAlD
Mirtazapine—HRH1—central nervous system—brain cancer	0.000163	0.00139	CbGeAlD
Mirtazapine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000162	0.00107	CcSEcCtD
Mirtazapine—Ill-defined disorder—Etoposide—brain cancer	0.000162	0.00107	CcSEcCtD
Mirtazapine—Anaemia—Etoposide—brain cancer	0.000161	0.00107	CcSEcCtD
Mirtazapine—Insomnia—Temozolomide—brain cancer	0.000161	0.00107	CcSEcCtD
Mirtazapine—Decreased appetite—Carmustine—brain cancer	0.00016	0.00106	CcSEcCtD
Mirtazapine—Paraesthesia—Temozolomide—brain cancer	0.00016	0.00106	CcSEcCtD
Mirtazapine—ADRA2A—central nervous system—brain cancer	0.00016	0.00136	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Carmustine—brain cancer	0.000159	0.00105	CcSEcCtD
Mirtazapine—ADRA2C—brain—brain cancer	0.000159	0.00136	CbGeAlD
Mirtazapine—Dyspnoea—Temozolomide—brain cancer	0.000159	0.00105	CcSEcCtD
Mirtazapine—Somnolence—Temozolomide—brain cancer	0.000158	0.00105	CcSEcCtD
Mirtazapine—Pain—Carmustine—brain cancer	0.000158	0.00104	CcSEcCtD
Mirtazapine—Constipation—Carmustine—brain cancer	0.000158	0.00104	CcSEcCtD
Mirtazapine—Malaise—Etoposide—brain cancer	0.000158	0.00104	CcSEcCtD
Mirtazapine—Vertigo—Etoposide—brain cancer	0.000157	0.00104	CcSEcCtD
Mirtazapine—Dyspepsia—Temozolomide—brain cancer	0.000157	0.00104	CcSEcCtD
Mirtazapine—Leukopenia—Etoposide—brain cancer	0.000156	0.00103	CcSEcCtD
Mirtazapine—ADRA2A—cerebellum—brain cancer	0.000156	0.00133	CbGeAlD
Mirtazapine—Diarrhoea—Hydroxyurea—brain cancer	0.000156	0.00103	CcSEcCtD
Mirtazapine—Decreased appetite—Temozolomide—brain cancer	0.000155	0.00102	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000154	0.00102	CcSEcCtD
Mirtazapine—Fatigue—Temozolomide—brain cancer	0.000154	0.00102	CcSEcCtD
Mirtazapine—Loss of consciousness—Etoposide—brain cancer	0.000154	0.00101	CcSEcCtD
Mirtazapine—Cough—Etoposide—brain cancer	0.000152	0.00101	CcSEcCtD
Mirtazapine—Pain—Temozolomide—brain cancer	0.000152	0.00101	CcSEcCtD
Mirtazapine—Constipation—Temozolomide—brain cancer	0.000152	0.00101	CcSEcCtD
Mirtazapine—Feeling abnormal—Carmustine—brain cancer	0.000152	0.001	CcSEcCtD
Mirtazapine—Convulsion—Etoposide—brain cancer	0.000151	0.001	CcSEcCtD
Mirtazapine—Hypertension—Etoposide—brain cancer	0.000151	0.000997	CcSEcCtD
Mirtazapine—Dizziness—Hydroxyurea—brain cancer	0.000151	0.000997	CcSEcCtD
Mirtazapine—HTR2A—endocrine gland—brain cancer	0.000151	0.00129	CbGeAlD
Mirtazapine—Gastrointestinal pain—Carmustine—brain cancer	0.000151	0.000996	CcSEcCtD
Mirtazapine—HTR2A—head—brain cancer	0.000149	0.00127	CbGeAlD
Mirtazapine—Chest pain—Etoposide—brain cancer	0.000149	0.000983	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000148	0.000976	CcSEcCtD
Mirtazapine—CYP2C8—brain—brain cancer	0.000147	0.00126	CbGeAlD
Mirtazapine—Discomfort—Etoposide—brain cancer	0.000147	0.000971	CcSEcCtD
Mirtazapine—Feeling abnormal—Temozolomide—brain cancer	0.000147	0.00097	CcSEcCtD
Mirtazapine—Body temperature increased—Carmustine—brain cancer	0.000146	0.000963	CcSEcCtD
Mirtazapine—Abdominal pain—Carmustine—brain cancer	0.000146	0.000963	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Temozolomide—brain cancer	0.000146	0.000963	CcSEcCtD
Mirtazapine—Vomiting—Hydroxyurea—brain cancer	0.000145	0.000958	CcSEcCtD
Mirtazapine—Rash—Hydroxyurea—brain cancer	0.000144	0.00095	CcSEcCtD
Mirtazapine—Confusional state—Etoposide—brain cancer	0.000144	0.00095	CcSEcCtD
Mirtazapine—Dermatitis—Hydroxyurea—brain cancer	0.000144	0.00095	CcSEcCtD
Mirtazapine—Headache—Hydroxyurea—brain cancer	0.000143	0.000944	CcSEcCtD
Mirtazapine—Infection—Etoposide—brain cancer	0.000142	0.000936	CcSEcCtD
Mirtazapine—Urticaria—Temozolomide—brain cancer	0.000142	0.000935	CcSEcCtD
Mirtazapine—Body temperature increased—Temozolomide—brain cancer	0.000141	0.000931	CcSEcCtD
Mirtazapine—Abdominal pain—Temozolomide—brain cancer	0.000141	0.000931	CcSEcCtD
Mirtazapine—Thrombocytopenia—Etoposide—brain cancer	0.00014	0.000923	CcSEcCtD
Mirtazapine—CYP3A4—endocrine gland—brain cancer	0.00014	0.00119	CbGeAlD
Mirtazapine—Tachycardia—Etoposide—brain cancer	0.000139	0.00092	CcSEcCtD
Mirtazapine—Skin disorder—Etoposide—brain cancer	0.000139	0.000915	CcSEcCtD
Mirtazapine—Hyperhidrosis—Etoposide—brain cancer	0.000138	0.000911	CcSEcCtD
Mirtazapine—CYP2D6—endocrine gland—brain cancer	0.000137	0.00117	CbGeAlD
Mirtazapine—Anorexia—Etoposide—brain cancer	0.000136	0.000898	CcSEcCtD
Mirtazapine—HTR2A—central nervous system—brain cancer	0.000136	0.00116	CbGeAlD
Mirtazapine—Hypersensitivity—Carmustine—brain cancer	0.000136	0.000898	CcSEcCtD
Mirtazapine—CYP2D6—head—brain cancer	0.000136	0.00116	CbGeAlD
Mirtazapine—Nausea—Hydroxyurea—brain cancer	0.000135	0.000895	CcSEcCtD
Mirtazapine—Hypotension—Etoposide—brain cancer	0.000133	0.00088	CcSEcCtD
Mirtazapine—HTR2A—cerebellum—brain cancer	0.000133	0.00113	CbGeAlD
Mirtazapine—Asthenia—Carmustine—brain cancer	0.000132	0.000874	CcSEcCtD
Mirtazapine—Hypersensitivity—Temozolomide—brain cancer	0.000131	0.000868	CcSEcCtD
Mirtazapine—HRH1—brain—brain cancer	0.000129	0.0011	CbGeAlD
Mirtazapine—Paraesthesia—Etoposide—brain cancer	0.000128	0.000846	CcSEcCtD
Mirtazapine—Asthenia—Temozolomide—brain cancer	0.000128	0.000845	CcSEcCtD
Mirtazapine—Dyspnoea—Etoposide—brain cancer	0.000127	0.00084	CcSEcCtD
Mirtazapine—ADRA2A—brain—brain cancer	0.000127	0.00108	CbGeAlD
Mirtazapine—Somnolence—Etoposide—brain cancer	0.000127	0.000838	CcSEcCtD
Mirtazapine—Diarrhoea—Carmustine—brain cancer	0.000126	0.000834	CcSEcCtD
Mirtazapine—Pruritus—Temozolomide—brain cancer	0.000126	0.000833	CcSEcCtD
Mirtazapine—CYP3A4—central nervous system—brain cancer	0.000126	0.00107	CbGeAlD
Mirtazapine—Decreased appetite—Etoposide—brain cancer	0.000124	0.000819	CcSEcCtD
Mirtazapine—CYP2D6—central nervous system—brain cancer	0.000124	0.00106	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Etoposide—brain cancer	0.000123	0.000813	CcSEcCtD
Mirtazapine—Fatigue—Etoposide—brain cancer	0.000123	0.000812	CcSEcCtD
Mirtazapine—Dizziness—Carmustine—brain cancer	0.000122	0.000806	CcSEcCtD
Mirtazapine—Constipation—Etoposide—brain cancer	0.000122	0.000806	CcSEcCtD
Mirtazapine—Pain—Etoposide—brain cancer	0.000122	0.000806	CcSEcCtD
Mirtazapine—Diarrhoea—Temozolomide—brain cancer	0.000122	0.000806	CcSEcCtD
Mirtazapine—CYP2D6—cerebellum—brain cancer	0.000121	0.00103	CbGeAlD
Mirtazapine—Dizziness—Temozolomide—brain cancer	0.000118	0.000779	CcSEcCtD
Mirtazapine—Feeling abnormal—Etoposide—brain cancer	0.000118	0.000776	CcSEcCtD
Mirtazapine—Vomiting—Carmustine—brain cancer	0.000117	0.000775	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Etoposide—brain cancer	0.000117	0.000771	CcSEcCtD
Mirtazapine—Rash—Carmustine—brain cancer	0.000116	0.000768	CcSEcCtD
Mirtazapine—Dermatitis—Carmustine—brain cancer	0.000116	0.000768	CcSEcCtD
Mirtazapine—Headache—Carmustine—brain cancer	0.000116	0.000763	CcSEcCtD
Mirtazapine—Vomiting—Temozolomide—brain cancer	0.000113	0.000749	CcSEcCtD
Mirtazapine—Urticaria—Etoposide—brain cancer	0.000113	0.000749	CcSEcCtD
Mirtazapine—Abdominal pain—Etoposide—brain cancer	0.000113	0.000745	CcSEcCtD
Mirtazapine—Body temperature increased—Etoposide—brain cancer	0.000113	0.000745	CcSEcCtD
Mirtazapine—Rash—Temozolomide—brain cancer	0.000112	0.000742	CcSEcCtD
Mirtazapine—Dermatitis—Temozolomide—brain cancer	0.000112	0.000742	CcSEcCtD
Mirtazapine—Headache—Temozolomide—brain cancer	0.000112	0.000738	CcSEcCtD
Mirtazapine—Nausea—Carmustine—brain cancer	0.00011	0.000724	CcSEcCtD
Mirtazapine—HTR2A—brain—brain cancer	0.000108	0.00092	CbGeAlD
Mirtazapine—Nausea—Temozolomide—brain cancer	0.000106	0.000699	CcSEcCtD
Mirtazapine—Hypersensitivity—Etoposide—brain cancer	0.000105	0.000694	CcSEcCtD
Mirtazapine—Asthenia—Etoposide—brain cancer	0.000102	0.000676	CcSEcCtD
Mirtazapine—Pruritus—Etoposide—brain cancer	0.000101	0.000667	CcSEcCtD
Mirtazapine—CYP2D6—brain—brain cancer	9.83e-05	0.000838	CbGeAlD
Mirtazapine—Diarrhoea—Etoposide—brain cancer	9.76e-05	0.000645	CcSEcCtD
Mirtazapine—Dizziness—Etoposide—brain cancer	9.43e-05	0.000623	CcSEcCtD
Mirtazapine—Vomiting—Etoposide—brain cancer	9.07e-05	0.000599	CcSEcCtD
Mirtazapine—Rash—Etoposide—brain cancer	8.99e-05	0.000594	CcSEcCtD
Mirtazapine—Dermatitis—Etoposide—brain cancer	8.98e-05	0.000594	CcSEcCtD
Mirtazapine—Headache—Etoposide—brain cancer	8.93e-05	0.00059	CcSEcCtD
Mirtazapine—Nausea—Etoposide—brain cancer	8.47e-05	0.00056	CcSEcCtD
Mirtazapine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	8.16e-06	0.000149	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SPP1—brain cancer	8.14e-06	0.000149	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—IL2—brain cancer	8.07e-06	0.000147	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SPP1—brain cancer	7.96e-06	0.000145	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—EGFR—brain cancer	7.94e-06	0.000145	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	7.93e-06	0.000145	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SPP1—brain cancer	7.92e-06	0.000145	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL2—brain cancer	7.92e-06	0.000145	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VAV1—brain cancer	7.87e-06	0.000144	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—APC—brain cancer	7.84e-06	0.000143	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	7.84e-06	0.000143	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—EGFR—brain cancer	7.82e-06	0.000143	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL2—brain cancer	7.74e-06	0.000141	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SPP1—brain cancer	7.7e-06	0.000141	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL2—brain cancer	7.57e-06	0.000138	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HES1—brain cancer	7.56e-06	0.000138	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL2—brain cancer	7.53e-06	0.000138	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IRS2—brain cancer	7.52e-06	0.000137	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—TP53—brain cancer	7.5e-06	0.000137	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—EGFR—brain cancer	7.48e-06	0.000137	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—HES1—brain cancer	7.44e-06	0.000136	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HES1—brain cancer	7.42e-06	0.000136	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.41e-06	0.000135	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IRS2—brain cancer	7.36e-06	0.000134	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CG—brain cancer	7.36e-06	0.000134	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL2—brain cancer	7.33e-06	0.000134	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—IL2—brain cancer	7.32e-06	0.000134	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—APC—brain cancer	7.29e-06	0.000133	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CG—brain cancer	7.29e-06	0.000133	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HES1—brain cancer	7.28e-06	0.000133	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—IL2—brain cancer	7.2e-06	0.000132	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PDGFRA—brain cancer	7.2e-06	0.000131	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IRS2—brain cancer	7.2e-06	0.000131	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ENO2—brain cancer	7.19e-06	0.000131	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—IL2—brain cancer	7.19e-06	0.000131	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IRS2—brain cancer	7.16e-06	0.000131	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—EGFR—brain cancer	7.14e-06	0.00013	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	7.08e-06	0.000129	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PDGFRA—brain cancer	7.07e-06	0.000129	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—IL2—brain cancer	7.05e-06	0.000129	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—IDH1—brain cancer	7.02e-06	0.000128	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SPP1—brain cancer	6.99e-06	0.000128	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IRS2—brain cancer	6.96e-06	0.000127	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	6.93e-06	0.000127	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SPP1—brain cancer	6.88e-06	0.000126	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SPP1—brain cancer	6.86e-06	0.000125	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—RELA—brain cancer	6.81e-06	0.000124	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HES1—brain cancer	6.77e-06	0.000124	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—ERBB2—brain cancer	6.77e-06	0.000124	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SPP1—brain cancer	6.73e-06	0.000123	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—RELA—brain cancer	6.7e-06	0.000122	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—ERBB2—brain cancer	6.66e-06	0.000122	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TP53—brain cancer	6.66e-06	0.000122	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL2—brain cancer	6.65e-06	0.000121	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CG—brain cancer	6.65e-06	0.000121	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—APC—brain cancer	6.65e-06	0.000121	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—EGFR—brain cancer	6.64e-06	0.000121	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	6.55e-06	0.00012	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL2—brain cancer	6.54e-06	0.00012	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL2—brain cancer	6.53e-06	0.000119	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—APC—brain cancer	6.5e-06	0.000119	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CG—brain cancer	6.5e-06	0.000119	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	6.44e-06	0.000118	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—RELA—brain cancer	6.42e-06	0.000117	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL2—brain cancer	6.41e-06	0.000117	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—ERBB2—brain cancer	6.38e-06	0.000116	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	6.36e-06	0.000116	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—APC—brain cancer	6.36e-06	0.000116	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	6.32e-06	0.000116	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—APC—brain cancer	6.32e-06	0.000116	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IRS2—brain cancer	6.32e-06	0.000115	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SPP1—brain cancer	6.26e-06	0.000114	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IRS2—brain cancer	6.22e-06	0.000114	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IRS2—brain cancer	6.2e-06	0.000113	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—APC—brain cancer	6.15e-06	0.000112	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	6.15e-06	0.000112	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL2—brain cancer	6.13e-06	0.000112	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—RELA—brain cancer	6.12e-06	0.000112	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IRS2—brain cancer	6.09e-06	0.000111	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—ERBB2—brain cancer	6.09e-06	0.000111	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—EGFR—brain cancer	6.05e-06	0.000111	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL2—brain cancer	6.04e-06	0.00011	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CCND1—brain cancer	5.98e-06	0.000109	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CG—brain cancer	5.97e-06	0.000109	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL2—brain cancer	5.95e-06	0.000109	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—EGFR—brain cancer	5.92e-06	0.000108	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CTNNB1—brain cancer	5.92e-06	0.000108	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CCND1—brain cancer	5.88e-06	0.000108	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CTNNB1—brain cancer	5.83e-06	0.000106	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—EGFR—brain cancer	5.79e-06	0.000106	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL2—brain cancer	5.78e-06	0.000106	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—EGFR—brain cancer	5.76e-06	0.000105	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—RELA—brain cancer	5.7e-06	0.000104	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ERBB2—brain cancer	5.66e-06	0.000103	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IRS2—brain cancer	5.66e-06	0.000103	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CCND1—brain cancer	5.63e-06	0.000103	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	5.6e-06	0.000102	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—APC—brain cancer	5.58e-06	0.000102	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CG—brain cancer	5.58e-06	0.000102	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CTNNB1—brain cancer	5.58e-06	0.000102	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ENO2—brain cancer	5.55e-06	0.000101	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL2—brain cancer	5.52e-06	0.000101	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—APC—brain cancer	5.49e-06	0.0001	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	5.49e-06	0.0001	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—APC—brain cancer	5.48e-06	0.0001	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CG—brain cancer	5.48e-06	0.0001	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CCND1—brain cancer	5.38e-06	9.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	5.38e-06	9.82e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—APC—brain cancer	5.38e-06	9.82e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	5.32e-06	9.73e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—VEGFA—brain cancer	5.21e-06	9.52e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—RELA—brain cancer	5.19e-06	9.49e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—ERBB2—brain cancer	5.16e-06	9.43e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—STAT3—brain cancer	5.16e-06	9.43e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL2—brain cancer	5.13e-06	9.38e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—VEGFA—brain cancer	5.13e-06	9.37e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—EGFR—brain cancer	5.08e-06	9.29e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—RELA—brain cancer	5.08e-06	9.28e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—STAT3—brain cancer	5.08e-06	9.28e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—ERBB2—brain cancer	5.05e-06	9.22e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CCND1—brain cancer	5e-06	9.14e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—EGFR—brain cancer	5e-06	9.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—APC—brain cancer	5e-06	9.13e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	5e-06	9.13e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—EGFR—brain cancer	4.99e-06	9.12e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—RELA—brain cancer	4.97e-06	9.07e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CTNNB1—brain cancer	4.95e-06	9.05e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—RELA—brain cancer	4.94e-06	9.03e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ERBB2—brain cancer	4.94e-06	9.02e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—VEGFA—brain cancer	4.91e-06	8.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ERBB2—brain cancer	4.91e-06	8.97e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—EGFR—brain cancer	4.9e-06	8.95e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—STAT3—brain cancer	4.86e-06	8.88e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—RELA—brain cancer	4.81e-06	8.78e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MYC—brain cancer	4.79e-06	8.76e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	4.78e-06	8.73e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CG—brain cancer	4.74e-06	8.66e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MYC—brain cancer	4.72e-06	8.62e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—EGFR—brain cancer	4.69e-06	8.57e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—VEGFA—brain cancer	4.69e-06	8.56e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL2—brain cancer	4.68e-06	8.54e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—STAT3—brain cancer	4.64e-06	8.48e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—EGFR—brain cancer	4.62e-06	8.43e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL2—brain cancer	4.57e-06	8.36e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CCND1—brain cancer	4.56e-06	8.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	4.55e-06	8.32e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MYC—brain cancer	4.52e-06	8.25e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CTNNB1—brain cancer	4.51e-06	8.25e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—brain cancer	4.47e-06	8.17e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCND1—brain cancer	4.46e-06	8.15e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—brain cancer	4.45e-06	8.13e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—brain cancer	4.42e-06	8.07e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CTNNB1—brain cancer	4.42e-06	8.07e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—brain cancer	4.36e-06	7.97e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RELA—brain cancer	4.36e-06	7.97e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCND1—brain cancer	4.36e-06	7.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCND1—brain cancer	4.34e-06	7.93e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB2—brain cancer	4.33e-06	7.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—brain cancer	4.33e-06	7.91e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STAT3—brain cancer	4.32e-06	7.89e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	4.32e-06	7.89e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MYC—brain cancer	4.31e-06	7.88e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	4.3e-06	7.85e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RELA—brain cancer	4.29e-06	7.84e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RELA—brain cancer	4.28e-06	7.82e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB2—brain cancer	4.26e-06	7.79e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB2—brain cancer	4.25e-06	7.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCND1—brain cancer	4.22e-06	7.71e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—brain cancer	4.22e-06	7.71e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RELA—brain cancer	4.2e-06	7.68e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	4.18e-06	7.63e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB2—brain cancer	4.18e-06	7.63e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—brain cancer	4.01e-06	7.33e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—brain cancer	3.97e-06	7.26e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—brain cancer	3.94e-06	7.19e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—brain cancer	3.94e-06	7.19e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—brain cancer	3.93e-06	7.18e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—brain cancer	3.93e-06	7.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RELA—brain cancer	3.9e-06	7.13e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CG—brain cancer	3.89e-06	7.11e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—brain cancer	3.89e-06	7.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	3.88e-06	7.09e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—brain cancer	3.88e-06	7.08e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—brain cancer	3.86e-06	7.06e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—brain cancer	3.86e-06	7.05e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—brain cancer	3.86e-06	7.04e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—brain cancer	3.85e-06	7.03e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCND1—brain cancer	3.83e-06	6.99e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—brain cancer	3.8e-06	6.95e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CTNNB1—brain cancer	3.79e-06	6.93e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—brain cancer	3.78e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—brain cancer	3.78e-06	6.91e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCND1—brain cancer	3.77e-06	6.88e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—brain cancer	3.76e-06	6.88e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCND1—brain cancer	3.76e-06	6.87e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—brain cancer	3.74e-06	6.84e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	3.73e-06	6.82e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CTNNB1—brain cancer	3.72e-06	6.8e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—brain cancer	3.71e-06	6.78e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCND1—brain cancer	3.69e-06	6.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	3.68e-06	6.72e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—brain cancer	3.66e-06	6.68e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	3.65e-06	6.67e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—brain cancer	3.64e-06	6.65e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—brain cancer	3.58e-06	6.53e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—brain cancer	3.58e-06	6.53e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—brain cancer	3.54e-06	6.47e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—brain cancer	3.52e-06	6.42e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—brain cancer	3.5e-06	6.39e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—brain cancer	3.5e-06	6.39e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—brain cancer	3.48e-06	6.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCND1—brain cancer	3.43e-06	6.26e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—brain cancer	3.42e-06	6.25e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—brain cancer	3.4e-06	6.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	3.39e-06	6.2e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—brain cancer	3.38e-06	6.18e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—brain cancer	3.34e-06	6.1e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—brain cancer	3.31e-06	6.05e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—brain cancer	3.3e-06	6.04e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.3e-06	6.03e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—brain cancer	3.3e-06	6.02e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—brain cancer	3.28e-06	6e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—brain cancer	3.28e-06	5.99e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—brain cancer	3.25e-06	5.94e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—brain cancer	3.24e-06	5.93e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—brain cancer	3.22e-06	5.87e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—brain cancer	3.18e-06	5.82e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—brain cancer	3.07e-06	5.61e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—brain cancer	3.02e-06	5.52e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—brain cancer	3.02e-06	5.51e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—brain cancer	3e-06	5.49e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—brain cancer	3e-06	5.49e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	2.99e-06	5.46e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—brain cancer	2.96e-06	5.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—brain cancer	2.96e-06	5.4e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—brain cancer	2.96e-06	5.4e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—brain cancer	2.95e-06	5.39e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—brain cancer	2.94e-06	5.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—brain cancer	2.89e-06	5.29e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—brain cancer	2.87e-06	5.25e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—brain cancer	2.86e-06	5.22e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—brain cancer	2.78e-06	5.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—brain cancer	2.75e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—brain cancer	2.69e-06	4.91e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.55e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—brain cancer	2.52e-06	4.61e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—brain cancer	2.48e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—brain cancer	2.48e-06	4.52e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—brain cancer	2.43e-06	4.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—brain cancer	2.26e-06	4.12e-05	CbGpPWpGaD
